News

News Medical on MSN21d
Long-term inhaled corticosteroid use for COPD linked to serious long-term health risks
Inhaled corticosteroids (ICS) are commonly prescribed for chronic obstructive pulmonary disease (COPD), but not recommended as first-line treatment unless patients have asthma/COPD overlap or frequent ...
European Medical Journal3d
Significant Risks Associated with Long-Term ICS Use in COPD Management
Long-term ICS use in COPD increases risks of severe health conditions like Type 2 diabetes and fractures. Read more!
Pharmaceutical Technology on MSN21d
EMA to review GSK’s Nucala for COPD treatment expansion
The European Medicines Agency (EMA) has agreed to review GSK’s application of expanding Nucala’s (mepolizumab) use as add-on maintenance for individuals with chronic obstructive pulmonary disease ...
Yahoo Finance18d
Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD
this approval was based on pivotal phase 3 results in adults with elevated eosinophils Approval marks the first new treatment approach for COPD in more than a decade in Japan and the sixth ...
Woman's World on MSN2mon
COPD Flare-up? Here's How to Breathe Easier and When to Call a Doctor
Chronic obstructive pulmonary disease (COPD), a condition that affects more than 14 million U.S. adults, is marked by damage ...